Article
Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
18 Apr 2023
Abstract excerpt
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. The disease, characterized by motor, cognitive, and psychiatric impairments, is caused by the expansion of a CAG repeat in the huntingtin gene. Despite the discovery of the mutation in 1993, no disease-modifying treatments are yet available. Understanding the molecular and cellular mechanisms involved in HD is therefore crucial for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
